- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Defining, Clarifying, & Implementing Digital Tools For Mental Health

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Defining, Clarifying, & Implementing Digital Tools For Mental Health
Digital tools are one of the newest therapeutic modalities for the prevention, management, or treatment of chronic, behavior-modifiable disease.1 In this webinar, Dr. Jake Behrens and Dr. Margaret Emerson will share their expertise in the utilization of digital tools. Together, they will define digital health tools, clarify their potential application in clinical practice, and describe digital tool implementation best practices.
Objectives:
- • Define Digital Heath Tools
• Clarify the Application of Digital Tools in Mental Health Treatment
• Outline the Implementation of Digital Tools in Clinical Practice
1 Patel NA, Butte AJ. Characteristics and challenges of the clinical pipeline of digital therapeutics NPJ Digit Med.2020;3:159.

Jake Behrens, MD
CEO & Medical Director, Regional Director Envision ADHD, Brightside Health

Margaret Emerson, DNP, APRN, PMHNP-BC
Clinical Associate Professor at the University of Nebraska Medical Center, Omaha, NE
More

Jason Carter, PharmD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs
Dr. Jake Behrens and Dr. Margaret Emerson are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Dr. Jason Carter is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).